Trial vaccine mix-and-match, delayed 2nd dose instead of Ivermectin, MOH told

Trial vaccine mix-and-match, delayed 2nd dose instead of Ivermectin, MOH told - Hello loyal readers FeedGoogle, In the article you are reading this time with the title Trial vaccine mix-and-match, delayed 2nd dose instead of Ivermectin, MOH told, We have prepared this article well for you to read and take information in it. hopefully the contents of the post Article Malaysians, what we write you can understand. Alright, happy reading.

DAP politician and general practitioner Dr Boo Cheng Hau has questioned the Health Ministry’s decision to trial Ivermectin on high-risk Covid-19 patients.This comes after India dropped the drug from its Covid-19 treatment guideline.Ivermectin is an anti-parasitic drug mostly used in veterinary medicine to treat worm infestations.In a statement, Boo opined that resources could be better utilised elsewhere.“The ministry should not throw scarce resources into clinical trials on the effectiveness of Ivermectin on Covid-19.“But instead, (it should conduct) trials on mix-and-match approach and the delayed second dose mass vaccination strategy to induce cross-immunity against the new variants.“Just hours ago, it’s reported that India has revised its Covid-19 treatment guidelines by dropping drugs such as Ivermectin, hydroxychloroquine, doxycycline, zinc and multivitamins [...]“Is it …